Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:IQV
IQVIA Holdings
|
231.18 | 17,25% | 34,12% | 42.121 | 0% | 12,94% |
|
SWX:LONN
Lonza Group
|
529.20 | -28,51% | -13,46% | 38.164,1 | 0,76% | 0,68% |
|
NasdaqGS:ICLR
ICON Public
|
314.72 | 8,72% | 23,9% | 26.022,25 | 0% | 16% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
210.59 | -11,18% | -1,65% | 17.751,4 | 1,37% | 4,24% |
|
SWX:SGSN
SGS
|
80.72 | 887,92% | 968,45% | 15.278,36 | 3,96% | -1,74% |
|
ENXTPA:ERF
Eurofins Scientific
|
58.26 | 14% | 29,25% | 11.046,73 | 0,86% | 7,46% |
|
NYSE:CRL
Charles River Laboratories International
|
221.61 | 15,62% | 31,45% | 11.815,07 | 0% | 12,09% |
|
BSE:500124
Dr. Reddy's Laboratories
|
5814.80 | 16,88% | 19% | 977.652,02 | 0,69% | 24,23% |
|
NYSE:CTLT
Catalent
|
55.37 | -57,27% | -6,76% | 10.100,49 | 0% | -10,41% |
|
SZSE:000963
Huadong Medicine
|
33.25 | 5,75% | 30,76% | 59.084,79 | 1,74% | 4,04% |
|
SZSE:300347
Hangzhou Tigermed Consulting
|
56.99 | 178,52% | 235,82% | 48.379,37 | 1% | 33,82% |
|
SZSE:300759
Pharmaron Beijing
|
22.22 | 280,08% | 376,88% | 33.918,69 | 0,9% | 25,74% |
|
SZSE:002821
Asymchem Laboratories (Tianjin)
|
80.84 | 412,47% | 525,32% | 29.605,47 | 2,23% | 40,54% |
|
SZSE:000513
Livzon Pharmaceutical Group
|
36.98 | 0% | 0% | 28.754,16 | 4,49% | 6,03% |
|
SHSE:603707
Nanjing King-Friend Biochemical
Pharmaceutical |
13.91 | 0% | 0% | 23.186,48 | 0,8% | 32,54% |
|
SHSE:603456
Zhejiang Jiuzhou Pharmaceutical
|
15.92 | 328,05% | 473,8% | 14.499,71 | 3,14% | 29,1% |
|
XTRA:EVT
Evotec
|
9.76 | -32,05% | 101,29% | 1.726,81 | 0% | 0% |
|
SEHK:1873
Viva Biotech Holdings
|
0.71 | 10,24% | 54,43% | 10.990,64 | 0% | -17,43% |
|
SZSE:300363
Porton Pharma Solutions
|
16.15 | 217,36% | 240,95% | 9.178,9 | 3,02% | 292,47% |
|
SEHK:1521
Frontage Holdings
|
1.26 | 414,23% | 509,82% | 2.488,08 | 0% | 0% |
